Neterton Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Neterton Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT07151508

Successful Treatment of Netherton Syndrome With Combination of Secukinumab and Dupilumab

In this study, we describe our experience with secukinumab (IL-17A inhibitor) and dupilumab (IL-4/IL-13 inhibitor) treatment of a group of pediatric patients wi…

Russia15 participantsStarted 2023-12-19

Treatment: Secukinumab was administered in a weight-adapted dosing regimen ? Dupilumab was administered at a dose dependent on the patient's weight and age